Monitoring populations for DNA repair deficiency and for cancer susceptibility

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 3, 1996, Pages 579-584

  Au, William W ^a   Wilkinson, Gregg S ^a   Tyring, Stephen K ^a   Legator, Marvin S ^a   El Zein, Randa ^a   Hallberg, Lance ^a   Heo, Moon Y ^b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b Kangwon National University   (South Korea)

Author keywords

Cancer susceptibility; Chromosome aberrations; DNA repair; Environmental toxicology; Genotoxicity; Predisposition

Indexed keywords

METHYLNITRONITROSOGUANIDINE; MUTAGENIC AGENT; TERATOGENIC AGENT; TOXIC SUBSTANCE;

ANIMAL CELL; CANCER SUSCEPTIBILITY; CHILD; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DNA REPAIR; DNA STRAND; DOWN SYNDROME; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; HEALTH HAZARD; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE; MONITORING; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROVOCATION TEST; SOMATIC CELL;

EID: 0029889351     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.96104s3579     Document Type: Conference Paper

References (40)

1. Awa AA, Honda T, Sofuni T, Neriishi S, Yoshida MC, Matsui T. Chromosome aberration frequency in cultured blood-cells in relation to radiation dose of A-bomb survivors. Lancet 2:903-905 (1971).
2. Bauchinger M. Cytogenetic effects in human lymphocytes as a dosimetry system. In: Biological Dosimetry (Eisert WB, Mendelsohn ML, eds). New York:Springer-Verlag, 1984; 15-24.
3. Bender MA, Wong RMA. Biological indicators of radiation quality. In: Reevaluations of Dosimetric Factors Hiroshima and Nagasaki (Bond VP and Thiessen JW, eds). CONF-810928, Washington:U.S. Department of Energy, 1982;223-240.
4. Sorsa M, Ojajarvi A, Salomaa S. Cytogenetic surveillance of workers exposed to genotoxic chemicals: preliminary experiences from a prospective cancer study in a cytogenetic cohort. Teratogenesis Carcinog Mutagen 10:215-221 (1990).
5. Hagmar L, Brogger A, Hansteen I-L, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, Reuterwall C, Salomaa S, Skerfuing S, Sorsa M. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922 (1994).
6. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ, Wachholz BW. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res 196:103-159 (1988).
7. Lucas JN, Awa A, Straume T, Poggensee M, Kodama Y, Nakano M, Ohtaki K, Weier H-U, Pinkel D, Gray J, Littlefield G. Rapid translocation frequency analysis in humans decades after exposure to ionizing radiation. Int J Radiat Biol 62:53-63 (1992).
8. Tucker JD, Ramsey MJ, Lee DA, Mikler JL. Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro. Int J Radiat Biol 64:27-37 (1993).
9. Rupa DS, Hasegawa L, Eastmond DA. Detection of chromosomal breakage in the 1 cen-1q12 region of interphase human lymphocytes using multicolor fluorescence in situ hybridization with tandem DNA probes. Cancer Res 55:640-645 (1995).
10. Loeb LA. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res 51:3075-3079 (1991).
11. Loeb LA. Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54:5059-5063 (1994).
12. Modrich P. Mismatch repair, genetic stability and cancer. Science 266:1959-1960 (1994).
13. 6-alkylguanine-DNA alkyltransferase activity in peripheral blood lymphocytes: relationship between this activity in lymphocytes and in lymphoblastoid lines from normal controls and from patients with Hodgkin's disease or non-Hodgkin's lymphoma. Cancer Res 49:5339-5344 (1989).
14. 6-methylguanine. Cancer Res 52:1801-1803 (1992).
15. Madden JJ, Falek A, Shater DA, Click JH. Effects of opiates and demographic factors on DNA repair synthesis in human leukocytes. Proc Natl Acad Sci USA 76:5769-5773 (1979).
16. Celotti L, Furlan D, Ferraro P, Levis AG. DNA repair and replication in lymphocytes from smokers exposed in vitro to UV-light. Mutagenesis 4:82-86 (1989).
17. Mayer J, Warburton D, Jeffrey AM, Pero R, Walles S, Andrews L, Toor M, Latriano L, Wazneh TD, Tsai W-Y, Kuroda M, Perera F. Biologic markers in ethylene oxide-exposed workers and controls. Mutat Res 248:163-176 (1991).
18. Au WW. Abnormal chromosome repair and risk of developing cancer. Environ Health Perspect 101 (Suppl 3):303-308 (1993).
19. Au WW, Walker DM, Ward JB, Whorton E, Legaror MS, Singh V. Factors contributing to chromosome damage in lymphocytes of cigarette smokers. Mutat Res 260:137-144 (1991).
20. Au WW, Ward JB Jr, Ramanujam VM, Harper BL, Moslen MT, Legator MS. Genotoxic effects of a sub-acute low-level inhalation exposure to a mixture of carcinogenic chemicals. Mutat Res 203:103-115 (1988).
21. Shafik HM, Au WW, Legator MS. Chromosomal radiosensitivity of Down syndrome lymphocytes at different stages of the cell cycle. Hum Genet 78:71-75 (1988).
22. Shafik HM, Au WW, Whorton EB, Legator MS. Distribution of X-ray induced chromosome breakpoints in Down syndrome lymphocytes. Am J Med Genet 57:195-200 (1990).
23. El Zein R, Tyring S, Au W. Chromosomal radiosensitivity of lymphocytes from skin-cancer prone patients. Mutat Res (in press).
24. Au WW, Bechtold WE, Whorton EB Jr, Legator MS. Chromosome aberrations and response to gamma-ray challenge in lymphocytes of workers exposed to 1,3-butadiene. Mutat Res 334:125-130 (1995).
25. Au WW, Lane RG, Legator MS, Whorton EB Jr, Wilkinson GS, Gabehart, GJ. Biomarker monitoring of a population residing near uranium mining activities. Environ Health Perspect 103:466-470 (1995).
26. Au WW, Rodriguez G, Rocco C, Legator MS, Wilkinson GS. Chromosome damage and DNA repair response in lymphocytes of women who had children with neural tube defects. Mutat Res (in press).
27. Athas WF, Hedayati MA, Matanoski GM, Farmer ER, Grossman L. Development and field-test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 51:5786-5793 (1991).
28. Hallberg LM, El Zain R, Grossman L, Au WW. Measurement of DNA repair deficiency in workers exposed to benzene. Environ Health Perspect 104(Suppl 3):529-534 (1996).
29. Kadlubar FF, Butler MA, Kaderlik KR, Chou H-C, Lang NP. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Perspect 98:69-74 (1992).
30. Idle JR, Daly AK. New opportunities in cancer risk evaluation using PCR-based DNA analysis for CYP2D6. Environ Health Perspect 101(Suppl 53): 117-120 (1993).
31. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA Jr. Human glutathione S-transferase deficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50:1585-1590 (1990).
32. Uuskula M, Jarventaus H, Hirvonen A, Sorsa M, Norppa H. Influence of CSTM1 genotype on sister chromatid exchange induction by styrene-7,8-oxide and 1,2-epoxy-3-butene in cultured human lymphocytes. Carcinogenesis 16:947-950 (1995).
33. El Zein R, Abdel-Rahman SZ, Zwischenberger JB, Au WW. Genetic polymorphism in cytochrome p450 2E1 and glutathione S-transferase M-1 genes: factors implicated in lung cancer [Abstract]. Environ Mo1 Mutagen 25(Suppl 25):59 (1995).
34. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878 (1994).
35. Schulte PA. A conceptual and historical framework for molecular epidemiology. In: Molecular Epidemiology: Principles and Practices (Schulte PA, ed). New York:Academic Press, 1993;3-43.
36. Hanania EG, Au WW, Ullrich RL, Papaconstantinou J. Involvement of the retinoblastoma gene in a mouse mammary tumor model. Cancer Res Ther Control 4:67-76 (1994).
37. Au WW, Anwar WW, Hanania EG. Chromosome, oncogene and tumor suppressor gene changes in mouse mammary tumor cells during transformation and after transfection. Cancer Res Ther Control 4:109-118 (1994).
38. Hanania EG, Au WW, Ullrich RL, Papaconstantinou J. Regulation of retinoblastoma gene expression in a mouse mammary tumor model. Cancer Gene Ther (in press).
39. McConnell MA, Ramanujam VMS, Alcock N, Au W. Distribution of uranium-238 and thorium-232 in soil samples determined by ICP-MS. Presented in the Environmental Mutagen Society Annual Conference, March 12-16 (1995).
40. Ward JB Jr, Ammenheuser MM, Bechtold WE, Whorton EB Jr, Legator MS. hprt mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ Health Perspect 102(SuPPl 9):79-85 (1994).